Integrins are heterodimeric transmembrane receptors consisting of one α and one β chain; among the αv class integrins, αvβ3 and αvβ5 have been targeted in cancer treatment and have been reported to play prominent roles in glioma cell adhesion, migration, angiogenesis and therapy resistance17,36–42. Here, NRP1 is linked to glioma.